Patent · US Active

BMI-1 protein expression modulators

US8680113B2 · kind B2 · utility

3Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2009
Grant dateMar 25, 2014
Priority date—
Expiry dateNov 3, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having Formula I:wherein the variables Ar1, Ar2, R1, R2 and R3 are defined herein, pharmaceutical compositions, and methods of using such compounds or compositions for inhibiting Bmi-1 expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.